Who
Robert M. Davis
Director
Company insider
Files Form 4 as: Director, Duke Energy Corporation (Holding Company); Chairman, CEO & President, Merck & Company; Director, Bard C R Inc /nj/; Corporate Vice President, Baxter International.
In numbers
- Trades disclosed
- 154
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $146.1M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 17 May 2006
- Last trade
- 7 May 2026
- Last filed
- 11 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 May 2026filed 11 May 2026 | DUK Duke Energy Corporation (Holding Company)Electric Utilities & IPPs | SEC FORM 4 Code A | $200K1,602 at $124.87 | filing |
| 7 May 2026filed 11 May 2026 | DUK Duke Energy Corporation (Holding Company)Electric Utilities & IPPs | SEC FORM 4 Code A | $200K1,602 at $124.87 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —47,724 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —139,697 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —47,724 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —139,697 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code M | $1.5M13,300 at $110.03 | filing |
| 29 Apr 2026filed 1 May 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code F | $721K6,551 at $110.03 | filing |
| 29 Apr 2026filed 1 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —13,300 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —13,300 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code M | $1.5M13,300 at $110.03 | filing |
| 29 Apr 2026filed 1 May 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code F | $721K6,551 at $110.03 | filing |
| 4 Feb 2026filed 6 Feb 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $1.8M14,972 at $117.38 | filing |
| 4 Feb 2026filed 6 Feb 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $3.8M32,462 at $118.35 | filing |
| 4 Feb 2026filed 6 Feb 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $1.8M14,972 at $117.38 | filing |
| 4 Feb 2026filed 6 Feb 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $3.8M32,462 at $118.35 | filing |
| 26 Jan 2026filed 28 Jan 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code A | $5.1M47,434 at $107.40 | filing |
| 26 Jan 2026filed 28 Jan 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code A | $5.1M47,434 at $107.40 | filing |
| 1 May 2025filed 5 May 2025 | DUK Duke Energy Corporation (Holding Company)Electric Utilities & IPPs | SEC FORM 4 Code A | $195K1,607 at $121.33 | filing |
| 29 Apr 2025filed 1 May 2025 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —39,901 at $0.00 | filing |
News
AbbVie vs. Merck: Which Pharma Stock Offers Better Value?MRK · insidermonkey.com · 16 Oct 2026Merck's Rally Reflects Renewed Confidence, but Has the Market Priced in Too Much?MRK · insidermonkey.com · 16 Oct 2026Merck & Co., Inc. $MRK Stock: Signal Advisors Wealth LLC Boosts StakeMRK · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Robert M. Davis; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.